Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-04

Clinical Trial Update: Prospective Survey of Menstrual Migraine & Prevention With Eletriptan [Phase 4]

View source ↗

Summary

Phase 4 clinical trial report on menstrual migraine and prevention using eletriptan; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RELPAX (Eletriptan hydrobromide)

Snippet

Sponsor: University of Pittsburgh | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2011-07-04